GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » ROE %

Grape King Bio (TPE:1707) ROE % : 17.80% (As of Dec. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Grape King Bio's annualized net income for the quarter that ended in Dec. 2024 was NT$1,787 Mil. Grape King Bio's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was NT$10,038 Mil. Therefore, Grape King Bio's annualized ROE % for the quarter that ended in Dec. 2024 was 17.80%.

The historical rank and industry rank for Grape King Bio's ROE % or its related term are showing as below:

TPE:1707' s ROE % Range Over the Past 10 Years
Min: 14.46   Med: 20.94   Max: 32.12
Current: 14.51

During the past 13 years, Grape King Bio's highest ROE % was 32.12%. The lowest was 14.46%. And the median was 20.94%.

TPE:1707's ROE % is ranked better than
79.46% of 959 companies
in the Drug Manufacturers industry
Industry Median: 4.82 vs TPE:1707: 14.51

Grape King Bio ROE % Historical Data

The historical data trend for Grape King Bio's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grape King Bio ROE % Chart

Grape King Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.88 16.66 15.70 14.86 14.46

Grape King Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.20 10.19 13.22 16.98 17.80

Competitive Comparison of Grape King Bio's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grape King Bio's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's ROE % distribution charts can be found below:

* The bar in red indicates where Grape King Bio's ROE % falls into.



Grape King Bio ROE % Calculation

Grape King Bio's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=1448.299/( (9978.299+10055.699)/ 2 )
=1448.299/10016.999
=14.46 %

Grape King Bio's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Sep. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=1787.088/( (10020.617+10055.699)/ 2 )
=1787.088/10038.158
=17.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


Grape King Bio  (TPE:1707) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1787.088/10038.158
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1787.088 / 12619.924)*(12619.924 / 14864.7685)*(14864.7685 / 10038.158)
=Net Margin %*Asset Turnover*Equity Multiplier
=14.16 %*0.849*1.4808
=ROA %*Equity Multiplier
=12.02 %*1.4808
=17.80 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1787.088/10038.158
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1787.088 / 3281.172) * (3281.172 / 3050.932) * (3050.932 / 12619.924) * (12619.924 / 14864.7685) * (14864.7685 / 10038.158)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5446 * 1.0755 * 24.18 % * 0.849 * 1.4808
=17.80 %

Note: The net income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Grape King Bio ROE % Related Terms

Thank you for viewing the detailed overview of Grape King Bio's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grape King Bio Business Description

Traded in Other Exchanges
N/A
Address
No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines